Ryo Itabashi Selected Research

Stents

2/2011

[Ocular ischemic syndrome improved by stent placement for stenosis at the orifice of the left common carotid artery].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ryo Itabashi Research Topics

Disease

21	Stroke (Strokes) 06/2023 - 10/2008
14	Ischemic Stroke 06/2023 - 12/2011
5	Cerebral Hemorrhage 01/2022 - 10/2008
5	Atrial Fibrillation 01/2020 - 08/2015
4	Hematoma 01/2022 - 05/2009
3	Infarction (Infarctions) 01/2023 - 01/2013
3	Transient Ischemic Attack 03/2021 - 01/2018
3	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2021 - 05/2009
3	Embolism (Embolus) 01/2021 - 01/2018
3	Hemorrhage 12/2018 - 05/2009
2	Venous Thrombosis (Deep-Vein Thrombosis) 01/2024 - 08/2015
2	Thrombosis (Thrombus) 02/2022 - 10/2020
2	Hyperglycemia 01/2021 - 01/2020
2	Intracranial Embolism 08/2015 - 01/2014
2	Pathologic Constriction (Stenosis) 12/2011 - 02/2011
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2024
1	Diabetes Mellitus 10/2022
1	Coma (Comas) 10/2022
1	Takayasu Arteritis (Arteritis, Takayasu's) 02/2022
1	Hemiplegia (Spastic Hemiplegia) 02/2022
1	Hemianopsia (Bitemporal Hemianopsia) 10/2021
1	Carotid Stenosis (Carotid Artery Stenosis) 01/2021
1	Acute Coronary Syndrome 01/2020
1	Aortic Aneurysm (Aneurysm, Aortic) 01/2020
1	Peripheral Arterial Disease 01/2020
1	Rupture 01/2020
1	Venous Thromboembolism 01/2020
1	Infections 01/2018
1	Hypertension (High Blood Pressure) 01/2018
1	Thromboembolism 08/2015
1	Thrombocytopenia (Thrombopenia) 08/2015
1	Embolic Stroke 01/2014
1	Heart Diseases (Heart Disease) 01/2014
1	Liver Diseases (Liver Disease) 01/2010
1	Putaminal Hemorrhage 05/2009

Drug/Important Bio-Agent (IBA)

6	Tissue Plasminogen Activator (Alteplase)FDA Link 06/2023 - 08/2019
4	AnticoagulantsIBA 01/2021 - 01/2011
4	Warfarin (Coumadin)FDA LinkGeneric 01/2019 - 01/2010
3	Antihypertensive Agents (Antihypertensives)IBA 10/2019 - 10/2008
2	Nicardipine (Dagan)FDA LinkGeneric 01/2022 - 01/2018
2	Blood Glucose (Blood Sugar)IBA 10/2021 - 01/2021
2	Cilostazol (Pletal)FDA LinkGeneric 01/2021 - 01/2013
1	Amyloid (Amyloid Fibrils)IBA 01/2024
1	fibrin fragment D (D-dimer)IBA 01/2023
1	C-Type Lectins (C-Type Lectin)IBA 01/2023
1	Cytochrome P-450 CYP2C19IBA 01/2023
1	Adenosine Diphosphate (ADP)IBA 03/2021
1	Purinergic P2Y Receptor AntagonistsIBA 03/2021
1	Clopidogrel (Plavix)FDA Link 03/2021
1	GadoliniumIBA 02/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	SodiumIBA 10/2019
1	fasudil (AT 877)IBA 10/2019
1	ozagrelIBA 10/2019
1	LipidsIBA 12/2018
1	Heparin (Liquaemin)FDA LinkGeneric 08/2015
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 12/2011
1	Prothrombin (Factor II)IBA 01/2011

Therapy/Procedure

5	Therapeutics 08/2021 - 10/2008
3	Thrombectomy 01/2023 - 10/2022
3	Carotid Endarterectomy 01/2021 - 01/2020
1	Early Ambulation 10/2022
1	Length of Stay 10/2022
1	Massage (Zone Therapy) 02/2022
1	Endarterectomy (Thromboendarterectomy) 01/2021
1	Percutaneous Coronary Intervention 01/2020
1	Secondary Prevention 01/2018
1	Catheter Ablation 08/2015
1	Catheters 08/2015
1	Punctures 08/2015
1	Stents 02/2011